Stock listing
SMMT Stock Price, News, Filings & Events — Summit Therapeutics Inc.
Selected listing: SMMT · BOATS · USD · US
This page tracks Summit Therapeutics Inc.'s SMMT:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SMMT:BOATS. SMMT:BOATS is the stock-level entry point for investors researching Summit Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. With a market capitalization of approximately $10.6 billion, the company focuses on developing innovative therapeutics for various medical conditions. Summit Therapeutics aims to address unmet medical needs through its advanced research and development initiatives.

- Ticker
- SMMT:BOATS
- Asset type
- Stock
- Market cap
- $10.50B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Summit Therapeutics Inc. SMMT:BOATS stock context
This page tracks Summit Therapeutics Inc.'s SMMT:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SMMT:BOATS. SMMT:BOATS is the stock-level entry point for investors researching Summit Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. With a market capitalization of approximately $10.6 billion, the company focuses on developing innovative therapeutics for various medical conditions. Summit Therapeutics aims to address unmet medical needs through its advanced research and development initiatives.
Latest news from Summit Therapeutics Inc.
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
August 25, 2026
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for First-Line Treatment of Patients with Squamous Non-Small Cell ...
August 12, 2026
Summit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer
August 5, 2026
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2026
July 23, 2026
Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western and Asian Patients in Updated Analysis from...
July 22, 2026
Research Summit Therapeutics Inc.
Summit Therapeutics Inc. investor report
Review AI stock analysis and investor report context for SMMT:BOATS.
Summit Therapeutics Inc. company profile
View the public company page for Summit Therapeutics Inc. on 6ix.
Summit Therapeutics Inc. news
Read company news and market updates connected to Summit Therapeutics Inc..
Summit Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Summit Therapeutics Inc..
Alternate listings
SMMT:NASDAQ
US · USD
Alternate listing for Summit Therapeutics Inc.; the primary context on this page is SMMT:BOATS.
SMMT:BMV
MX · MXN
Alternate listing for Summit Therapeutics Inc.; the primary context on this page is SMMT:BOATS.
SMMT:BIVA
MX · MXN
Alternate listing for Summit Therapeutics Inc.; the primary context on this page is SMMT:BOATS.